Light and chemical control of neuronal circuits: possible applications in neurotherapy

References

• Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol 2000;57(3):418-20
   PubMed Web of Science ®Google Scholar
• Deisseroth K. Circuit dynamics of adaptive and maladaptive behaviour. Nature 2014;505(7483):309-17
   PubMedGoogle Scholar
• Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009;41(1):25-34
   PubMed Web of Science ®Google Scholar
• Jia H, Lubetkin EI. Trends in quality-adjusted life-years lost contributed by smoking and obesity. Am J Prev Med 2010;38(2):138-44
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(6):593-602
   PubMed Web of Science ®Google Scholar
• Perestelo-Perez L, Rivero-Santana A, Perez-Ramos J, et al. Deep brain stimulation in Parkinson’s disease: meta-analysis of randomized controlled trials. J Neurol 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Morishita T, Fayad SM, Goodman WK, et al. Surgical neuroanatomy and programming in deep brain stimulation for obsessive compulsive disorder. Neuromodulation 2014;17(4):312-19
   PubMed Web of Science ®Google Scholar
• Holtzheimer PE 3rd, Mayberg HS. Deep brain stimulation for treatment-resistant depression. Am J Psychiatry 2010;167(12):1437-44
   PubMed Web of Science ®Google Scholar
• Canavero S, Paolotti R, Bonicalzi V, et al. Extradural motor cortex stimulation for advanced Parkinson disease. Report of two cases. J Neurosurg 2002;97(5):1208-11
   PubMed Web of Science ®Google Scholar
• Gradinaru V, Mogri M, Thompson KR, et al. Optical deconstruction of parkinsonian neural circuitry. Science 2009;324(5925):354-9
   PubMed Web of Science ®Google Scholar
• Zhang F, Gradinaru V, Adamantidis AR, et al. Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat Protoc 2010;5(3):439-56
   PubMed Web of Science ®Google Scholar
• Boyden ES, Zhang F, Bamberg E, et al. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 2005;8(9):1263-8
   PubMed Web of Science ®Google Scholar
• Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annu Rev Neurosci 2011;34:389-412
   PubMed Web of Science ®Google Scholar
• Bamann C, Gueta R, Kleinlogel S, et al. Structural guidance of the photocycle of channelrhodopsin-2 by an interhelical hydrogen bond. Biochemistry 2010;49(2):267-78
   PubMedGoogle Scholar
• Grimm D, Lee JS, Wang L, et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J Virol 2008;82(12):5887-911
   PubMed Web of Science ®Google Scholar
• Airan RD, Thompson KR, Fenno LE, et al. Temporally precise in vivo control of intracellular signalling. Nature 2009;458(7241):1025-9
   PubMed Web of Science ®Google Scholar
• Oh E, Maejima T, Liu C, et al. Substitution of 5-HT1A receptor signaling by a light-activated G protein-coupled receptor. J Biol Chem 2010;285(40):30825-36
   PubMed Web of Science ®Google Scholar
• Armbruster BN, Li X, Pausch MH, et al. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci USA 2007;104(12):5163-8
   PubMed Web of Science ®Google Scholar
• Guettier JM, Gautam D, Scarselli M, et al. A chemical-genetic approach to study G protein regulation of beta cell function in vivo. Proc Natl Acad Sci USA 2009;106(45):19197-202
   PubMedGoogle Scholar
• Krashes MJ, Koda S, Ye C, et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest 2011;121(4):1424-8
   PubMed Web of Science ®Google Scholar
• Sasaki K, Suzuki M, Mieda M, et al. Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS One 2011;6(5):e20360
   Google Scholar
• Wess J, Nakajima K, Jain S. Novel designer receptors to probe GPCR signaling and physiology. Trends Pharmacol Sci 2013;34(7):385-92
   PubMedGoogle Scholar
• Magnus CJ, Lee PH, Atasoy D, et al. Chemical and genetic engineering of selective ion channel-ligand interactions. Science 2011;333(6047):1292-6
   PubMedGoogle Scholar
• Armstrong C, Krook-Magnuson E, Oijala M, Soltesz I. Closed-loop optogenetic intervention in mice. Nat Protoc 2013;8(8):1475-93
   PubMedGoogle Scholar
• Paz JT, Davidson TJ, Frechette ES, et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat Neurosci 2013;16(1):64-70
   PubMed Web of Science ®Google Scholar
• Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health 2008;29:115-29
   PubMed Web of Science ®Google Scholar
• Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006;7(2):137-51
   PubMed Web of Science ®Google Scholar
• Covington HE 3rd, Vialou V, Nestler EJ. From synapse to nucleus: novel targets for treating depression. Neuropharmacology 2010;58(4-5):683-93
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Barrot M, DiLeone RJ, et al. Neurobiology of depression. Neuron 2002;34(1):13-25
   PubMed Web of Science ®Google Scholar
• Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970;117(539):437-8
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006;59(12):1151-9
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Gould E, Manji H, et al. Preclinical models: status of basic research in depression. Biol Psychiatry 2002;52(6):503-28
   PubMed Web of Science ®Google Scholar
• Hamani C, Nobrega JN. Deep brain stimulation in clinical trials and animal models of depression. Eur J Neurosci 2010;32(7):1109-17
   PubMedGoogle Scholar
• Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285(10):1299-307
   PubMed Web of Science ®Google Scholar
• Giacobbe P, Mayberg HS, Lozano AM. Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol 2009;219(1):44-52
   PubMed Web of Science ®Google Scholar
• Rabins P, Appleby BS, Brandt J, et al. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry 2009;66(9):931-7
   PubMed Web of Science ®Google Scholar
• Haber SN, Brucker JL. Cognitive and limbic circuits that are affected by deep brain stimulation. Front Biosci (Landmark Ed) 2009;14:1823-34
   PubMedGoogle Scholar
• Lammel S, Lim BK, Malenka RC. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 2014;76(Pt B):351-9
   PubMedGoogle Scholar
• Lammel S, Tye KM, Warden MR. Progress in understanding mood disorders: optogenetic dissection of neural circuits. Genes Brain Behav 2014;13(1):38-51
   PubMed Web of Science ®Google Scholar
• Yehuda R, LeDoux J. Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron 2007;56(1):19-32
   PubMed Web of Science ®Google Scholar
• Shin LM, Wright CI, Cannistraro PA, et al. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 2005;62(3):273-81
   PubMed Web of Science ®Google Scholar
• Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005;48(2):175-87
   PubMed Web of Science ®Google Scholar
• Krishnan V, Han MH, Graham DL, et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007;131(2):391-404
   PubMed Web of Science ®Google Scholar
• Cao JL, Covington HE 3rd, Friedman AK, et al. Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J Neurosci 2010;30(49):16453-8
   PubMed Web of Science ®Google Scholar
• Frith CD, Frith U. Social cognition in humans. Curr Biol 2007;17(16):R724-32
   PubMed Web of Science ®Google Scholar
• Hyman SE. How mice cope with stressful social situations. Cell 2007;131(2):232-4
   PubMedGoogle Scholar
• Chaudhury D, Walsh JJ, Friedman AK, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013;493(7433):532-6
   PubMed Web of Science ®Google Scholar
• Tye KM, Mirzabekov JJ, Warden MR, et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2013;493(7433):537-41
   PubMed Web of Science ®Google Scholar
• Berton O, McClung CA, Dileone RJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006;311(5762):864-8
   PubMed Web of Science ®Google Scholar
• Marmigere F, Givalois L, Rage F, et al. Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 2003;13(5):646-55
   PubMed Web of Science ®Google Scholar
• Carter ME, Yizhar O, Chikahisa S, et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 2010;13(12):1526-33
   PubMed Web of Science ®Google Scholar
• Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001;411(6836):480-4
   PubMed Web of Science ®Google Scholar
• Ollmann MM, Wilson BD, Yang YK, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997;278(5335):135-8
   PubMed Web of Science ®Google Scholar
• Roseberry AG, Liu H, Jackson AC, et al. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 2004;41(5):711-22
   PubMedGoogle Scholar
• Balthasar N, Coppari R, McMinn J, et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 2004;42(6):983-91
   PubMed Web of Science ®Google Scholar
• Elmquist JK, Coppari R, Balthasar N, et al. Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol 2005;493(1):63-71
   PubMed Web of Science ®Google Scholar
• Coppari R, Ichinose M, Lee CE, et al. The hypothalamic arcuate nucleus: a key site for mediating leptin’s effects on glucose homeostasis and locomotor activity. Cell Metab 2005;1(1):63-72
   PubMed Web of Science ®Google Scholar
• Dampney RA. Arcuate nucleus - a gateway for insulin’s action on sympathetic activity. J Physiol 2011;589(Pt 9):2109-10
   PubMedGoogle Scholar
• Groba C, Mayerl S, van Mullem AA, et al. Hypothyroidism compromises hypothalamic leptin signaling in mice. Mol Endocrinol 2013;27(4):586-97
   PubMedGoogle Scholar
• Kohno D, Gao HZ, Muroya S, et al. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003;52(4):948-56
   PubMed Web of Science ®Google Scholar
• Jovanovic Z, Yeo GS. Central leptin signalling: beyond the arcuate nucleus. Auton Neurosci 2010;156(1-2):8-14
   PubMedGoogle Scholar
• Ring LE, Zeltser LM. Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels. J Clin Invest 2010;120(8):2931-41
   PubMedGoogle Scholar
• Aponte Y, Atasoy D, Sternson SM. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat Neurosci 2011;14(3):351-5
   PubMed Web of Science ®Google Scholar
• Krashes MJ, Shah BP, Madara JC, et al. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature 2014;507(7491):238-42
   PubMed Web of Science ®Google Scholar
• Choudhury AI, Heffron H, Smith MA, et al. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 2005;115(4):940-50
   PubMed Web of Science ®Google Scholar
• Kong D, Tong Q, Ye C, et al. GABAergic RIP-Cre neurons in the arcuate nucleus selectively regulate energy expenditure. Cell 2012;151(3):645-57
   PubMed Web of Science ®Google Scholar
• Cao WH, Madden CJ, Morrison SF. Inhibition of brown adipose tissue thermogenesis by neurons in the ventrolateral medulla and in the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 2010;299(1):R277-90
   PubMed Web of Science ®Google Scholar
• Lammel S, Lim BK, Ran C, et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012;491(7423):212-17
   PubMed Web of Science ®Google Scholar
• Kim SY, Adhikari A, Lee SY, et al. Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 2013;496(7444):219-23
   PubMed Web of Science ®Google Scholar
• Deisseroth K, Feng G, Majewska AK, et al. Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci 2006;26(41):10380-6
   PubMedGoogle Scholar
• Zhang F, Wang LP, Boyden ES, Deisseroth K. Channelrhodopsin-2 and optical control of excitable cells. Nat Methods 2006;3(10):785-92
   PubMed Web of Science ®Google Scholar
• Abilez OJ, Wong J, Prakash R, et al. Multiscale computational models for optogenetic control of cardiac function. Biophys J 2011;101(6):1326-34
   PubMedGoogle Scholar
• Busskamp V, Duebel J, Balya D, et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 2010;329(5990):413-17
   PubMed Web of Science ®Google Scholar
• Busskamp V, Picaud S, Sahel JA, Roska B. Optogenetic therapy for retinitis pigmentosa. Gene Ther 2012;19(2):169-75
   PubMed Web of Science ®Google Scholar
• Simonelli F, Maguire AM, Testa F, et al. Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 2010;18(3):643-50
   PubMed Web of Science ®Google Scholar
• Diester I, Kaufman MT, Mogri M, et al. An optogenetic toolbox designed for primates. Nat Neurosci 2011;14(3):387-97
   PubMed Web of Science ®Google Scholar
• Cavanaugh J, Monosov IE, McAlonan K, et al. Optogenetic inactivation modifies monkey visuomotor behavior. Neuron 2012;76(5):901-7
   PubMed Web of Science ®Google Scholar
• Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci 2011;34:289-307
   PubMed Web of Science ®Google Scholar
• Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 2008;21(4):583-93
   PubMed Web of Science ®Google Scholar
• Zaiss AK, Liu Q, Bowen GP, et al. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002;76(9):4580-90
   PubMedGoogle Scholar
• Kim TI, McCall JG, Jung YH, et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 2013;340(6129):211-16
   PubMed Web of Science ®Google Scholar
• Lin JY, Knutsen PM, Muller A, et al. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci 2013;16(10):1499-508
   PubMed Web of Science ®Google Scholar
• Chang WH, Lin SK, Lane HY, et al. Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 1998;22(5):723-39
   PubMedGoogle Scholar